Histamine H3 receptor activation potentiates peripheral opioid-mediated antinociception: Substance P role in peripheral inflammation in mice

European Journal of Pharmacology

Volumn 638, Issue 1-3, 2010, Pages 72-77

  Fernández Dueñas, Víctor ^a   Ciruela, Francisco ^a   Gandía, Jorge ^a   Sánchez, Sílvia ^a   Planas, Eulàlia ^a   Poveda, Raquel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Fentanyl; Histamine H3 receptor agonist; Inflammation; Nociception; Substance P; Synergy

Indexed keywords

ALPHA METHYLHISTAMINE; FENTANYL; FENTANYL CITRATE; HISTAMINE H3 RECEPTOR; NALOXONE; NEUROKININ 1 RECEPTOR ANTAGONIST; OPIATE; SUBSTANCE P; THIOPERAMIDE; ANALGESIC AGENT; FREUND ADJUVANT; HISTAMINE AGONIST; HISTAMINE DERIVATIVE; PIPERIDINE DERIVATIVE;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HYPERALGESIA; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG ANTAGONISM; DRUG COMBINATION; METABOLISM; PAIN; SKIN;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FENTANYL; FREUND'S ADJUVANT; HISTAMINE AGONISTS; HYPERALGESIA; INFLAMMATION; MALE; METHYLHISTAMINES; MICE; NALOXONE; PAIN; PIPERIDINES; RECEPTORS, HISTAMINE H3; SKIN; SUBSTANCE P;

EID: 77953538005     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.022     Document Type: Article

References (49)

1. Arrang J.M., Garbarg M., Lancelot J.C., Lecomte J.M., Pollard H., Robba M., Schunack W., Schwartz J.C. Highly potent and selective ligands for histamine H3-receptors. Nature 1987, 327:117-123.
2. Bianchi M., Franchi S., Ferrario P., Sotgiu M.L., Sacerdote P. Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain. Eur. J. Pain 2008, 12:284-292.
3. Börzsei R., Pozsgai G., Bagoly T., Elekes K., Pintér E., Szolcsányi J., Helyes Z. Inhibitory action of endomorphin-1 on sensory neuropeptide release and neurogenic inflammation in rats and mice. Neuroscience 2008, 152:82-88.
4. Buvanendran A., Kroin J.S. Useful adjuvants for postoperative pain management. Best Pract. Res. Clin. Anaesthesiol. 2007, 21:31-49.
5. Cannon K.E., Nalwalk J.W., Stadel R., Ge P., Lawson D., Silos-Santiago I., Hough L.B. Activation of spinal histamine H3 receptors inhibits mechanical nociception. Eur. J. Pharmacol. 2003, 470:139-147.
6. Cannon K.E., Chazot P.L., Hann V., Shenton F., Hough L.B., Rice F.L. Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia and spinal cord: potential antinociceptive targets. Pain 2007, 129:76-92.
7. Cerinic M.M., Konttinen Y., Generini S., Cutolo M. Neuropeptides and steroid hormones in arthritis. Curr. Opin. Rheumatol. 1998, 10:220-235.
8. Delaunois A., Gustin P., Garbarg M., Ansay M. Modulation of acetylcholine, capsaicin and substance P effects by histamine H3 receptors in isolated perfused rabbit lungs. Eur. J. Pharmacol. 1995, 277:243-250.
9. Dimitriadou V., Rouleau A., Trung T., Newlands G.J., Miller H.R., Luffau G., Schwartz J.C., Garbarg M. Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience 1997, 77:829-839.
10. Dray A. Inflammatory mediators of pain. Br. J. Anaesth. 1995, 75:125-131.
11. Farzin D., Asghari L., Nowrouzi M. Rodent antinociception following acute treatment with different histamine receptor agonists and antagonists. Pharmacol. Biochem. Behav. 2002, 72:751-760.
12. Fernández-Dueñas V., Pol O., García-Nogales P., Hernández L., Planas M.E., Puig M.M. Tolerance to the antinociceptive and antiexudative effects of morphine in a murine model of peripheral inflammation. J. Pharmacol. Exp. Ther. 2007, 322:360-368.
13. Fernández-Dueñas V., Sánchez S., Planas E., Poveda R. Adjuvant effect of caffeine on acetylsalicylic acid antinociception: prostaglandin E2 synthesis determination in carrageenan-induced peripheral inflammation in rat. Eur. J. Pain 2008, 12:157-163.
14. Ferre S., Ciruela F., Woods A.S., Lluis C., Franco R. Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci. 2007, 30:440-446.
15. Goodwin J.L., Kraemer J.J., Bajwa Z.H. The use of opioids in the treatment of osteoarthritis: when, why, and how?. Curr. Rheumatol. Rep. 2009, 11:5-14.
16. Helyes Z., Pintér E., Németh J., Szolcsányi J. Pharmacological targets for the inhibition of neurogenic inflammation. Curr. Med. Chem. AIAA 2003, 2:191-218.
17. Hernández L., Romero A., Almela P., García-Nogales P., Laorden M.L., Puig M.M. Tolerance to the antinociceptive effects of peripherally administered opioids. Expression of β-arrestins. Brain Res. 2009, 1248:31-39.
18. Huang L., Adachi N., Nagaro T., Liu K., Arai T. Histaminergic involvement in neuropathic pain produced by partial ligation of the sciatic nerve in rats. Reg. Anesth. Pain Med. 2007, 32:124-129.
19. Imamura M., Smith N.C., Garbarg M., Levi R. Histamine H3-receptor-mediated inhibition of calcitonin gene-related peptide release from cardiac C fibers. A regulatory negative-feedback loop. Circ. Res. 1996, 78:863-869.
20. Janson W., Stein C. Peripheral opioid analgesia. Curr. Pharm. Biotechnol. 2003, 4:270-274.
21. Jensen M.K., Thomsen A.B., Hojsted J. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization. Eur. J. Pain 2006, 10:423-433.
22. Labuz D., Berger S., Mousa S.A., Zollner C., Ritter H.L., Shaqura M.A., Segovia-Silvestre T., Przwelocka B., Stein C., Machelska H. Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. J. Neurosci. 2006, 26:4350-4358.
23. Maggi C.A. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog. Neurobiol. 1995, 45:1-98.
24. Malmberg-Aiello P., Lamberti C., Ghelardini C., Giotti A., Bartolini A. Role of histamine in rodent antinociception. Br. J. Pharmacol. 1994, 111:1269-1279.
25. McLeod R.L., Aslanian R., del Prado M., Duffy R., Egan R.W., Kreutner W., McQuade R., Hey J.A. Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig. J. Pharmacol. Exp. Ther. 1998, 287:43-50.
26. McQuay H. Opioids in pain management. Lancet 1999, 353:2229-2232.
27. Mobarakeh J.I., Takahashi K., Yanai K. Enhanced morphine-induced antinociception in histamine H3 receptor gene knockout mice. Neuropharmacology 2009, 57:409-414.
28. Mousa S.A., Zhang Q., Sitte N., Ji R., Stein C. Beta-endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J. Neuroimmunol. 2001, 115:71-78.
29. Nemmar A., Delaunois A., Beckers J.F., Sulon J., Bloden S., Gustin P. Modulatory effect of imetit, a histamine H3 receptor agonist, on C-fibers, cholinergic fibers and mast cells in rabbit lungs in vitro. Eur. J. Pharmacol. 1999, 371:23-30.
30. O'Connor T.M., O'Connell J., O'Brien D.I., Goode T., Bredin C.P., Shanahan F. The role of substance P in inflammatory disease. J. Cell Physiol. 2004, 201:167-180.
31. Ohkubo T., Shibata M., Inoue M., Kaya H., Takahashi H. Regulation of substance P release mediated via prejunctional histamine H3 receptors. Eur. J. Pharmacol. 1995, 273:83-88.
32. Oluyomi A.O., Hart S.L. Involvement of histamine in naloxone-resistant and naloxone-sensitive models of swim stress induced antinociception in the mouse. Neuropharmacology 1991, 30:1021-1027.
33. Owen S.M., Sturman G., Freeman P. Modulation of morphine-induced antinociception in mice by histamine H3-receptor ligands. Agents Actions 1994, 41:C62-C63.
34. Perrot S., Guibaud G., Kayser V. Differential effects of peripheral and systemic morphine and naloxone in a rat model of repeated acute inflammation. Anesthesiology 2001, 94:870-875.
35. Poveda R., Fernández-Dueñas V., Fernández A., Sánchez S., Puig M.M., Planas E. Synergistic interaction between fentanyl and the histamine H3-receptor agonist R-(α)-methylhistamine, on the inhibition of nociception and plasma extravasation in mice. Eur. J. Pharmacol. 2006, 541:53-56.
36. Przewlocki R., Przewlocka B. Opioids in chronic pain. Eur. J. Pharmacol. 2001, 429:79-91.
37. Rittner H.L., Brack A., Stein C. Pain and the immune system. Br. J. Anaesth. 2008, 101:40-44.
38. Rouleau A., Garbarg M., Ligneau X., Mantion C., Lavie P., Advenier C., Lecomte J.M., Krause M., Stark H., Schunack W., Schwartz J.C. Bioavailability, antinociceptive and antiinflammatory properties of BP 2-94, a histamine H3 receptor agonist prodrug. J. Pharmacol. Exp. Ther. 1997, 281:1085-1094.
39. Rouleau A., Stark H., Schunack W., Schwartz J.C. Antiinflammatory and antinociceptive properties of BP 2-94, a histamine H3-receptor agonist prodrug. J. Pharmacol. Exp. Ther. 2000, 295:219-225.
40. Sluka K.A., Milton M.A., Willis W.D., Westlund K.N. Differential roles of neurokinin 1 and neurokinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation. Br. J. Pharmacol. 1997, 120:1263-1273.
41. Stein C., Machelska H., Schafer M. Peripheral analgesic and antiinflammatory effects of opioids. Z. Rheumatol. 2001, 60:416-424.
42. Stein C., Schafer M., Machelska H. Attacking pain at its source: new perspectives on opioids. Nat. Med. 2003, 9:1003-1008.
43. Tallarida R.J. Statistical analysis of drug combinations for synergism. Pain 1992, 49:93-97.
44. Tallarida R.J. Drug synergism: its detection and applications. J. Pharmacol. Exp. Ther. 2001, 298:865-872.
45. White D.M. Release of substance P from peripheral sensory nerve terminals. J. Peripher. Nerv. Syst. 1997, 2:191-201.
46. Wilder-Smith C.H., Hill L., Spargo K., Kalla A. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID's: a randomised study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001, 91:23-31.
47. Yonehara N., Yoshimura M. Influence of painful chronic neuropathy on neurogenic inflammation. Pain 2001, 92:259-265.
48. Yonehara N., Imai Y., Chen J.Q., Takiuchi S., Inoki R. Influence of opioids on substance P release evoked by antidromic stimulation of primary afferent fibres in the hind instep of rats. Regul. Pept. 1992, 38:13-22.
49. Zampeli E., Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. Br. J. Pharmacol. 2009, 157:24-33.